AI-generated summary
The authors retrospectively reviewed 26 Korean patients with lupus erythematosus or dermatomyositis treated with various energy-based laser and light devices. They report significant improvement in erythema, dyspigmentation and skin morphology, with only transient side effects and no disease reactivation. The study was uncontrolled, and the authors state that larger controlled studies are needed to confirm efficacy.
- Participants
- 26
- Who or what was studied
- Korean patients with lupus erythematosus (20) and dermatomyositis (6) treated at Hanyang University Seoul Hospital from 2015 to 2023
- Limits stated in the abstract
- The retrospective study was uncontrolled, and the authors state that larger controlled studies are needed to confirm efficacy and optimal protocols.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
The use of energy-based devices (EBDs) for aesthetic and dermatological conditions is increasing, but data on efficacy and safety in autoimmune connective tissue disease (CTD) patients remain limited.
Objectives
This study assesses EBD real-world treatment outcomes in Korean patients with lupus erythematosus (LE) and dermatomyositis (DM).
Methods
A retrospective, uncontrolled study was conducted on 26 CTD patients (LE: 20, DM: 6) treated at Hanyang University Seoul Hospital (2015-2023). Various laser modalities, including pulsed-dye laser (PDL), intense pulsed light (IPL), long-pulse Nd:YAG (LPNY), Q-switched Nd:YAG (QSNY), and ablative fractional laser (AFL), were analyzed. Two independent dermatologists evaluated treatment outcomes using a 5-point modified Investigator's Global Assessment (IGA) scale.
Results
Patients showed significant improvement in erythema, dyspigmentation, and overall skin morphology. Some LE patients also exhibited enhanced follicular activity. Treatments were well-tolerated, with only transient side effects reported, and no long-term complications or disease reactivation occurred.
Conclusions
EBD treatments may provide cosmetic improvement in selected LE and DM patients and are generally safe. Larger controlled studies are needed to confirm efficacy and establish optimal protocols.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.